The identification of novel targets of miR-16 and characterization of their biological functions in cancer cells

Molecular Cancer

Volumn 12, Issue 1, 2013, Pages 1-11

  Yan, Xin ^a   Liang, Hongwei ^b   Deng, Ting ^a   Zhu, Kegan ^b   Zhang, Suyang ^b   Wang, Nan ^b   Jiang, Xueyuan ^b   Wang, Xueliang ^b   Liu, Rui ^a   Zen, Ke ^b   Zhang, Chen Yu ^b   Ba, Yi ^a   Chen, Xi ^b  

^a TIANJIN MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

Author keywords

CDS2; MAP7; microRNA; miR 16; PRDM4

Indexed keywords

LUCIFERASE; MESSENGER RNA; MICRORNA 16; DNA BINDING PROTEIN; MICRORNA; MICROTUBULE ASSOCIATED PROTEIN; MIRN16 MICRORNA, HUMAN; PRDM4 PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

APOPTOSIS; ARTICLE; BIOLOGICAL FUNCTIONS; CANCER CELL; CANCER CELL CULTURE; CELL CYCLE; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CELL VIABILITY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; MICROARRAY ANALYSIS; PLASMID; PROTEIN EXPRESSION; REPORTER GENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; WESTERN BLOTTING; BASE PAIRING; BIOLOGY; CELL TRANSFORMATION; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; NEOPLASM; NUCLEOTIDE SEQUENCE; TUMOR CELL LINE;

EUKARYOTA;

APOPTOSIS; BASE PAIRING; BASE SEQUENCE; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; CELL TRANSFORMATION, NEOPLASTIC; COMPUTATIONAL BIOLOGY; DNA-BINDING PROTEINS; GENE EXPRESSION; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, REPORTER; HUMANS; MICRORNAS; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASMS; RNA, MESSENGER; TRANSCRIPTION FACTORS;

EID: 84882666193     PISSN: None     EISSN: 14764598     Source Type: Journal    
DOI: 10.1186/1476-4598-12-92     Document Type: Article

References (21)

1. Pasquinelli AE. MicroRNAs and their targets: recognition, regulation and an emerging reciprocal relationship. Nat Rev Genet 2012, 13:271-282.
2. Peláez N, Carthew RW. Biological robustness and the role of microRNAs: a network perspective. Curr Top Dev Biol 2012, 99:237-255.
3. Nana-Sinkam SP, Croce CM. Clinical applications for microRNAs in cancer. Clin Pharmacol Ther 2013, 93:98-104. 10.1038/clpt.2012.192, 23212103.
4. Melo SA, Kalluri R. Molecular pathways: microRNAs as cancer therapeutics. Clin Cancer Res 2012, 18:4234-4239. 10.1158/1078-0432.CCR-11-2010, 22711704.
5. Lages E, Ipas H, Guttin A, Nesr H, Berger F, Issartel JP. MicroRNAs: molecular features and role in cancer. Front Biosci 2012, 17:2508-2540.
6. Calin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, Aldler H, Rattan S, Keating M, Rai K, Rassenti L, Kipps T, Negrini M, Bullrich F, Croce CM. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci USA 2002, 99:15524-15529. 10.1073/pnas.242606799, 137750, 12434020.
7. Aqeilan RI, Calin GA, Croce CM. miR-15a and miR-16-1 in cancer: discovery, function and future perspectives. Cell Death Differ 2010, 17:215-220. 10.1038/cdd.2009.69, 19498445.
8. Cimmino A, Calin GA, Fabbri M, Iorio MV, Ferracin M, Shimizu M, Wojcik SE, Aqeilan RI, Zupo S, Dono M, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. miR-15 and miR-16 induce apoptosis by targeting BCL2. Proc Natl Acad Sci USA 2005, 102:13944-13949. 10.1073/pnas.0506654102, 1236577, 16166262.
9. Linsley PS, Schelter J, Burchard J, Kibukawa M, Martin MM, Bartz SR, Johnson JM, Cummins JM, Raymond CK, Dai H, Chau N, Cleary M, Jackson AL, Carleton M, Lim L. Transcripts targeted by the microRNA-16 family cooperatively regulate cell cycle progression. Mol Cell Biol 2007, 27:2240-2252. 10.1128/MCB.02005-06, 1820501, 17242205.
10. Liu Q, Fu H, Sun F, Zhang H, Tie Y, Zhu J, Xing R, Sun Z, Zheng X. miR-16 family induces cell cycle arrest by regulating multiple cell cycle genes. Nucleic Acids Res 2008, 36:5391-5404. 10.1093/nar/gkn522, 2532718, 18701644.
11. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, D'Urso L, Pagliuca A, Biffoni M, Labbaye C, Bartucci M, Muto G, Peschle C, De Maria R. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Nat Med 2008, 14:1271-1277. 10.1038/nm.1880, 18931683.
12. Calin GA, Ferracin M, Cimmino A, Di Leva G, Shimizu M, Wojcik SE, Iorio MV, Visone R, Sever NI, Fabbri M, Iuliano R, Palumbo T, Pichiorri F, Roldo C, Garzon R, Sevignani C, Rassenti L, Alder H, Volinia S, Liu CG, Kipps TJ, Negrini M, Croce CM. A MicroRNA signature associated with prognosis and progression in chronic lymphocytic leukemia. N Engl J Med 2005, 353:1793-1801. 10.1056/NEJMoa050995, 16251535.
13. Bandi N, Zbinden S, Gugger M, Arnold M, Kocher V, Hasan L, Kappeler A, Brunner T, Vassella E. miR-15a and miR-16 are implicated in cell cycle regulation in a Rb-dependent manner and are frequently deleted or down-regulated in non-small cell lung cancer. Cancer Res 2009, 69:5553-5559. 10.1158/0008-5472.CAN-08-4277, 19549910.
14. Huntzinger E, Izaurralde E. Gene silencing by microRNAs: contributions of translational repression and mRNA decay. Nat Rev Genet 2011, 12:99-110. 10.1038/nrg2936, 21245828.
15. Lewis BP, Shih IH, Jones-Rhoades MW, Bartel DP, Burge CB. Prediction of mammalian microRNA targets. Cell 2003, 115:787-798. 10.1016/S0092-8674(03)01018-3, 14697198.
16. Krek A, Grün D, Poy MN, Wolf R, Rosenberg L, Epstein EJ, MacMenamin P, da Piedade I, Gunsalus KC, Stoffel M, Rajewsky N. Combinatorial microRNA target predictions. Nat Genet 2005, 37:495-500. 10.1038/ng1536, 15806104.
17. John B, Enright AJ, Aravin A, Tuschl T, Sander C, Marks DS. Human MicroRNA targets. PLoS Biol 2004, 2:e363. 10.1371/journal.pbio.0020363, 521178, 15502875.
18. Wang K, Li P, Dong Y, Cai X, Hou D, Guo J, Yin Y, Zhang Y, Li J, Liang H, Yu B, Chen J, Zen K, Zhang J, Zhang CY, Chen X. A microarray-based approach identifies ADP ribosylation factor-like protein 2 as a target of microRNA-16. J Biol Chem 2011, 286:9468-9476. 10.1074/jbc.M110.178335, 3058993, 21199864.
19. Masson D, Kreis TE. Binding of E-MAP-115 to microtubules is regulated by cell cycle-dependent phosphorylation. J Cell Biol 1995, 131:1015-1024. 10.1083/jcb.131.4.1015, 2200015, 7490279.
20. Ferguson SE, Olshen AB, Viale A, Awtrey CS, Barakat RR, Boyd J. Gene expression profiling of tamoxifen-associated uterine cancers: evidence for two molecular classes of endometrial carcinoma. Gynecol Oncol 2004, 92:719-725. 10.1016/j.ygyno.2003.10.038, 14766275.
21. Blum C, Graham A, Yousefzadeh M, Shrout J, Benjamin K, Krishna M, Hoda R, Hoda R, Cole DJ, Garrett-Mayer E, Reed C, Wallace M, Mitas M. The expression ratio of Map7/B2M is prognostic for survival in patients with stage II colon cancer. Int J Oncol 2008, 33:579-584. 3399116, 18695889.